Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms

Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms

Mucopolysaccharidoses (MPS) are the group of lysosomal storage disorders caused by deficiencies of enzymes involved in the stepwise degradation of glycosaminoglycans. To identify brain pathology common for neurological MPS, we conducted a comprehensive analysis of brain cortex tissues from post-mort...

Full description

Bibliographic Details
Main Authors:	Gustavo M. Viana, David A. Priestman, Frances M. Platt, Shaukat Khan, Shunji Tomatsu, Alexey V. Pshezhetsky
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	Journal of Clinical Medicine
Subjects:	mucopolysaccharidosis brain pathology neuroinflammation glycosaminoglycans glycosphingolipids protein misfolding
Online Access:	https://www.mdpi.com/2077-0383/9/2/396

Similar Items

Differences in MPS I and MPS II Disease Manifestations
by: Christiane S. Hampe, et al.
Published: (2021-07-01)

Glaucoma in mucopolysaccharidoses
by: Weijing Kong, et al.
Published: (2021-07-01)

Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy
by: Gustavo M. Viana, et al.
Published: (2011-01-01)

Prenatal genetic testing, counseling and follow-up of 33 Egyptian pregnant females with history of mucopolysaccharidoses
by: Khaled R. Gaber, et al.
Published: (2015-04-01)

Epidemiology of Mucopolysaccharidoses Update
by: Betul Çelik, et al.
Published: (2021-02-01)

Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice
by: Ainslie L. K. Derrick-Roberts, et al.
Published: (2017-02-01)

Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives
by: Francyne Kubaski, et al.
Published: (2020-11-01)

Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS)
by: Karolina M. Stepien, et al.
Published: (2020-05-01)

Upper Limb Pathology in Children with Mucopolysaccharidoses
by: V. M. Kenis, et al.
Published: (2021-07-01)

The importance of the otorhinolaryngologic evaluation in mucopolysaccharidosis patients
by: Bicalho, Cibele Gomes, et al.
Published: (2011-07-01)

Ophthalmological Findings in Mucopolysaccharidoses
by: Shizuka Tomatsu, et al.
Published: (2019-09-01)

An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan
by: Hsiang-Yu Lin, et al.
Published: (2019-10-01)

Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders
by: Paige C. Amendum, et al.
Published: (2021-08-01)

Alteration of the Total Cellular Glycome during Late Differentiation of Chondrocytes
by: Kentaro Homan, et al.
Published: (2019-07-01)

First Report of a Patient with MPS Type VII, Due to Novel Mutations in <i>GUSB</i>, Who Underwent Enzyme Replacement and Then Hematopoietic Stem Cell Transplantation
by: Patricia Dubot, et al.
Published: (2019-10-01)

Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients
by: Akhil Bhalla, et al.
Published: (2020-07-01)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
by: Nivethitha Arunkumar, et al.
Published: (2021-07-01)

Electromyography in diagnostic of median nerve lesion in carpal tunnel syndrome of children with mucopolysaccharidoses
by: A. L. Kurenkov, et al.
Published: (2015-02-01)

Terapia de reposição enzimática para as mucopolissacaridoses I, II e VI: recomendações de um grupo de especialistas brasileiros Enzyme replacement therapy for mucopolysaccharidoses I, II and VI: recommendations from a group of Brazilian F experts
by: Roberto Giugliani, et al.
Published: (2010-01-01)

Anesthesiological risks in mucopolysaccharidoses
by: Alessandra Moretto, et al.
Published: (2018-11-01)

Common N-acetylgalactosamine-6-sulfate sulfatase (GALNS) exon mutations in Brazilian patients with mucopolysaccharidosis IVA (MPS IVA)
by: Tatiana Dieter, et al.
Published: (2007-01-01)

Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies
by: Karolina Pierzynowska, et al.
Published: (2020-02-01)

Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
by: Thomas J. Langan, et al.
Published: (2020-03-01)

Multiple Roles of Glycans in Hematological Malignancies
by: Xingchen Pang, et al.
Published: (2018-09-01)

Functional independence of Taiwanese patients with mucopolysaccharidoses
by: Chung‐Lin Lee, et al.
Published: (2019-08-01)

Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01)

The levels of urinary glycosaminoglycans of patients with attenuated and severe type of mucopolysaccharidosis II determined by liquid chromatography-tandem mass spectrometry
by: Ryuichi Mashima, et al.
Published: (2016-06-01)

Mucopolysaccharidoses: A rare cause for bilateral cloudy cornea
by: Jayshri Vipin Ekhar, et al.
Published: (2017-01-01)

Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses
by: Shunji Tomatsu, et al.
Published: (2014-08-01)

Newborn screening in mucopolysaccharidoses
by: Maria Alice Donati, et al.
Published: (2018-11-01)

Visual Dysfunction of Type I and VI Mucopolysaccharidosis Patients Evaluated with Visual Evoked Cortical Potential
by: Bruno Duarte Gomes, et al.
Published: (2012-03-01)

Diagnosis of Mucopolysaccharidoses
by: Francyne Kubaski, et al.
Published: (2020-03-01)

Validation of Liquid Chromatography-Tandem Mass Spectrometry-Based 5-Plex Assay for Mucopolysaccharidoses
by: Tsubasa Oguni, et al.
Published: (2020-03-01)

A Case Report of Mucopolysaccharidosis Type VI
by: SJ Hosseini, et al.
Published: (2018-12-01)

EFFICACY AND SAFETY OF ENZYME REPLACEMENT THERAPY IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS TYPE I, II, AND VI: A SINGLE-CENTER COHORT STUDY
by: Liliia A. Osipova, et al.
Published: (2018-04-01)

Mucopolysaccharidoses diagnosis in the era of enzyme replacement therapy in Egypt
by: Ekram Fateen, et al.
Published: (2021-08-01)

Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
by: Hsiang-Yu Lin, et al.
Published: (2020-11-01)

Recent Advances in Cellular Glycomic Analyses
by: Yasuro Shinohara, et al.
Published: (2013-02-01)

Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
by: Rossella Parini, et al.
Published: (2020-04-01)

Evaluation of Multiple Methods for Quantification of Glycosaminoaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
by: Zackary M. Herbst, et al.
Published: (2020-08-01)